NCT01168037

Brief Summary

The aim of this study is to prospectively compare the perioperative mortality severe morbidity and the costs of endovascular versus conventional surgical repair of pararenal, supra-renal and type 4 THORACO-abdominal aortic aneurysms. The primary goal of the study is to demonstrate a significant drop in 30-day mortality and life threatening morbidity in the endovascular arm of the study. Our hypothesis, derived from the literature, that the average 30-days mortality is 3% after endovascular repair and 10% after open surgery justifies the design of a prospective study between endovascular therapy (250 patients (amendment) treated in 8 University hospitals with significant experience of the technique) and open repair (660 similar patients analyzed form the national database of the MOH).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 17, 2009

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 22, 2010

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2015

Completed
Last Updated

October 19, 2017

Status Verified

October 1, 2017

Enrollment Period

5.7 years

First QC Date

July 21, 2010

Last Update Submit

October 18, 2017

Conditions

Keywords

AortaAneurysmendovascularstent-graft

Outcome Measures

Primary Outcomes (1)

  • 30-day postoperative mortality

    30-day postoperative

Secondary Outcomes (8)

  • complications

    30-day postoperative

  • Length of Intensive Care Unit (ICU) stay

    30-day postoperative

  • Length of Hospital stay

    30-day postoperative

  • Overall cost

    30-day postoperative

  • Reinterventions

    2-year follow up

  • +3 more secondary outcomes

Study Arms (3)

Open repair

Open Surgical Repair (aortic replacement with revascularization of visceral arteries)

Procedure: Open Surgical Repair

Endovascular (Windows 1)

Endovascular therapy branched or fenestrated stent-graft

Device: Endovascular aortic repair with branched/fenestrated stent-graft

Endovascular (Windows 3)

Endovascular therapy branched or fenestrated stent-graft (vascutek anaconda)

Device: Endovascular aortic repair with branched/fenestrated stent-graft

Interventions

Insertion via bilateral femoral access, stent-graft deployment under fluoroscopic guidance, complementary stenting of visceral arteries, control angiogram

Also known as: Endovascular aortic repair
Endovascular (Windows 1)Endovascular (Windows 3)

aortic replacement with revascularization of visceral arteries

Open repair

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients with an Abdominal aortic aneurysm over 5 cm in diameter or with a diameter increase over 1 cm in 1 year and a PSRAA defined by: * Infrarenal aortic neck \< 15 mm * or extent of the aneurismal process to the suprarenal aorta

You may qualify if:

  • Absence of significant angulations (\< 60°) of aorta or of iliac arteries
  • Absence of tight stenosis (\>70%) of more than one target artery (renal or visceral artery to be perfused from the side holes of the stent-graft)
  • Diameter of target arteries over 5 mm
  • Iliac and femoral arteries allowing insertion of the delivery system (\> 7 mm) or suitable for insertion of an access conduit

You may not qualify if:

  • Limited expected life expectancy
  • Emergency cases
  • Refuse to participate to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henri Mondor Hospital

Créteil, 94010, France

Location

Related Publications (4)

  • O'Neill S, Greenberg RK, Haddad F, Resch T, Sereika J, Katz E. A prospective analysis of fenestrated endovascular grafting: intermediate-term outcomes. Eur J Vasc Endovasc Surg. 2006 Aug;32(2):115-23. doi: 10.1016/j.ejvs.2006.01.015. Epub 2006 Mar 31.

    PMID: 16580236BACKGROUND
  • Michel M, Becquemin JP, Clement MC, Marzelle J, Quelen C, Durand-Zaleski I; WINDOW Trial Participants. Editor's choice - thirty day outcomes and costs of fenestrated and branched stent grafts versus open repair for complex aortic aneurysms. Eur J Vasc Endovasc Surg. 2015 Aug;50(2):189-96. doi: 10.1016/j.ejvs.2015.04.012. Epub 2015 Jun 19.

  • Marzelle J, Presles E, Becquemin JP; WINDOWS trial participants. Results and factors affecting early outcome of fenestrated and/or branched stent grafts for aortic aneurysms: a multicenter prospective study. Ann Surg. 2015 Jan;261(1):197-206. doi: 10.1097/SLA.0000000000000612.

  • Banno H, Kobeiter H, Brossier J, Marzelle J, Presles E, Becquemin JP. Inter-observer variability in sizing fenestrated and/or branched aortic stent-grafts. Eur J Vasc Endovasc Surg. 2014 Jan;47(1):45-52. doi: 10.1016/j.ejvs.2013.10.008. Epub 2013 Oct 23.

MeSH Terms

Conditions

Aortic AneurysmAneurysm

Interventions

Endovascular Aneurysm Repair

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesAortic Diseases

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeBlood Vessel Prosthesis ImplantationVascular GraftingMinimally Invasive Surgical ProceduresProsthesis Implantation

Study Officials

  • Jean-Pierre Becquemin, PU-PH

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2010

First Posted

July 22, 2010

Study Start

June 17, 2009

Primary Completion

February 9, 2015

Study Completion

February 9, 2015

Last Updated

October 19, 2017

Record last verified: 2017-10

Locations